Evaluation of myelotoxicity in dietary restricted rats

Journal of Toxicologic Pathology

Volumn 22, Issue 1, 2009, Pages 53-63

  Miyata, Hiroto ^a   Asanuma, Fumiko ^a   Iwaki, Yoshinobu ^a   Kimura, Masaaki ^a   Matsumoto, Kiyoshi ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Dietary restriction; Food consumption; Myelotoxicity; Rat

Indexed keywords

FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW TOXICITY; CONTROLLED STUDY; DIET RESTRICTION; ERYTHROCYTE COUNT; EXTRAMEDULLARY HEMATOPOIESIS; FEEDING BEHAVIOR; FLUID INTAKE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; NONHUMAN; ORGAN WEIGHT; RAT; RETICULOCYTE COUNT; THROMBOCYTE COUNT; TOXICITY TESTING;

EID: 70349680621     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.22.53     Document Type: Article

References (31)

1. Yoshii A, Shiraishi Y, Ogawa S, Kinomoto T, Iino T, Matsui A, Sawada M, Hamano H, Kuroda H, Hayashi Y, Nishi N, Mera Y, and Takei M. Effects of food restriction on result of hematology examination and urinalysis in CD(SD)IGS rat - a four-week restricted feeding examination with two-week recovery period in six-week-old rats-. In: Biological Reference Data on CD(SD)IGS Rats- 2002/2003, Y Maeda and K Shibuya (eds). Best Printing, Tokyo. 73-84. 2003.
2. Oishi S, Oishi H, and Hiraga K. The effect of food restriction for 4 weeks on common toxicity parameters in male rats. Toxicol Appl Pharmacol. 47: 15-22. 1979.
3. Pickering RG and Pickering CE. The effects of reduced dietary intake upon the body and organ weights, and some clinical chemistry and haematological variates of the young Wistar rat. Toxicol Lett. 21: 271-277. 1984.
4. Moriyama T, Miyazawa H, Tomohiro M, Fujikake N, Samura K, and Nishikibe M. Beneficial effect of moderate food restriction in toxicity studies in rats. J Toxicol Sci. 31: 197-206. 2006.
5. Levin S, Semler D, and Ruben Z. Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol Pathol. 21: 1-14. 1993.
6. Sheldon WG, Bucci TJ, Hart RW, and Turturro A. Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. Toxicol Pathol. 23: 458-476. 1995.
7. Weindruch R. The retardation of aging by caloric restriction: studies in rodents and primates. Toxicol Pathol. 24: 742-745. 1996.
8. Hubert MF, Laroque P, Gillet JP, and Keenan KP. The effects of diet, ad libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats. Toxicol Sci. 58: 195-207. 2000.
9. Hartmann KU and Heidelberger C. Study on fluorinated pyrimidines. J Biological Chem. 236: 3006-3013. 1961.
10. Duschinsky R, Pleven E, and Heidelberger C. The synthesis of 5-fluoropyrimidines. J Am Chem Soc. 79: 4559-4560. 1957.
11. Stevenson DL, Mikhailidis DP, and Gillet DS. Cardiotoxicity of 5-fluorouracil. Lancet. 2: 406-407. 1977.
12. Soukop M, McVie JG, and Calman KC. Fluorouracil cardiotoxicity. Brit Med J. 1: 1422. 1978.
13. Janet A, Houghton JA, Houghton PJ, and Wooten RS. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-Fluorouracil, 5-Fluorouridine, and 5-Fluoro-2′-deoxyuridine. Cancer Res. 39: 2406-2413. 1979.
14. Tsuchiya M, Hayasaka S, and Mizuno K. Affinity of ocular acid-insoluble melanin for drugs in vitro. Invest Ophthalmol Vis Sci. 28: 822-825. 1987.
15. Shuey DL, Lau C, Logsdon TR, Zucker RM, Elstein KH, Narotsky MG, Setzer RW, Kavlock RJ, and Rogers JM. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol. 126: 129-144. 1994.
16. Lau C, Mole ML, Copeland MF, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, and Setzer RW. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data. Toxicol Sci. 59: 37-48. 2001.
17. Futamura Y and Matsumoto K. Characteristics of peripheral blood monocytes and bone marrow macrophages from rats treated with mitomycin C, 5-fluorouracil or phenylhydrazine. J Toxcol Sci. 20: 1-20. 1995.
18. Matsumura-Takeda K, Kotosai K, Ozaki A, Hara H, and Yamashita S. Rat granulocyte colony-forming unit (CFU-G) assay for the assessment of drug-induced hematotoxicity. Toxicol In Vitro. 16: 281-288. 2002.
19. Schonwald S. Antineoplastic drugs. In: Medical Toxicology. 3rd ed, RC Dart (ed). Lippincott Williams & Wilkins, Philadelphia. 494-541. 2004.
20. Irons RD. Blood and bone marrow. In: Handbook of Toxicologic Pathology, WM Haaschek, and CG Rousseaux (eds). Academic Press, San Diego. 389-419. 1991.
21. Vos JG and Kuper CF. Chemically-induced immunopathology and immune functional changes. J Toxcol Sci. 17: 137-146. 2004.
22. Hossain MM, Nakayama H, Shinozuka J, Katayama K, Suzuki K, and Doi K. 5-Azacytidine-induced apoptosis in lymphoid and hematopoietic organs of adult mice. J Toxcol Pathol. 13: 231-236. 2000.
23. Doi K, Shinozuka J, and Sehata S. T-2 toxin and apoptosis. J Toxcol Pathol. 19: 15-27. 2006.
24. Matsumoto K, Usui A, Ochiai T, Sekita K, Kawasaki Y, Naito K, Nakaji Y, Furuya T, and Tobe M. Short-tearm toxicity study of 4-dimethylaminoazobenzen in marmosets. J Toxicol Sci. 11: 335-343. 1986.
25. Matsumoto K. Studies on bone marrow cells in experimental animals: bone marrow testing in the safety study. Exp Anim. 40: 17-26. 1991.
26. Ogawa Y, Matsumoto K, Kamata E, Ikeda Y, and Kaneko T. Effect of feed restriction on peripheral blood and bone marrow cell counts of Wistar rats. Exp Anim. 34: 407-416. 1985.
27. Miyazaki H, Imamura S, Koyama K, Hara T, Nishikawa S, Shiramizu K, Ohguro Y, and Shimizu M. Safety evaluation of oral 5-fluorouracil (acute, subacute, chronic toxicity and teratological studies). Kiso to Rinsho. 8: 2603-2640. 1974 (in Japanese).
28. Hodgson GS and Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 281: 381-382. 1979.
29. Gopinath C, Prentice DE, and Lewis DJ. The lymphoid system. In: Atlas of Experimental Toxicological Pathology, GA Gresham (ed). MTP press, Lancaster. 122-136. 1987.
30. Tewari SP, Srivastava RK, Verma MP, and Zaidi SHH. Effect of 5-fluorouracil on rat bone marrow. Indian J Cancer. 21: 99-101. 1984.
31. Mitsumori K, Takegawa K, Shimo T, Onodera H, Yasuhara K, and Takahashi M. Morphometric and immunohistochemical studies on atrophic changes in lympho-hematopoietic organs of rats treated with piperonyl butoxide or subjected to dietary restriction. Arch Toxicol. 70: 809-814. 1996.